4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-22-001792
Options or other derivatives
- PRESIDENT OF R&D AND CMO acquired 65,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Huber Martin H. Jr. PRESIDENT OF R&D AND CMO | 2022-02-22 | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | D | ||
Loading xslF345X03/form4-02242022_050208.xml…